205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
67.24%
Net income growth 1.25-1.5x MRVL's 56.19%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-16.67%
Negative yoy D&A while MRVL is 870.60%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
6.25%
Deferred tax of 6.25% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
21.12%
Less working capital growth vs. MRVL's 182.53%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
-111.41%
Negative yoy inventory while MRVL is 275.61%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
64.52%
Some yoy usage while MRVL is negative at -1796.35%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-96.42%
Both negative yoy, with MRVL at -100.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-62.05%
Negative yoy CFO while MRVL is 346.70%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
49.15%
Some CapEx rise while MRVL is negative at -70.43%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
37.20%
Purchases growth of 37.20% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-33.69%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
47.66%
We have mild expansions while MRVL is negative at -152.59%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-66.67%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
1.18%
Buyback growth of 1.18% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.